COGNITION THERAPEUTICS
0.3979
27-November-24 16:45:00
15 minutes delayed
Stocks
-0.0066
-1.63%
Today's range
0.3750 - 0.4085
ISIN
N/A
Source
NASDAQ
-
Cognition Therapeutics to Report Fourth Quarter and Full Year 2022 Results
16 Mar 2023 07:30:53 By Nasdaq GlobeNewswire
-
15 Mar 2023 07:30:16 By Nasdaq GlobeNewswire
-
Cognition Therapeutics to Present at the 33rd Annual Oppenheimer & Co Annual Healthcare Conference
07 Mar 2023 08:00:13 By Nasdaq GlobeNewswire
-
22 Feb 2023 08:00:02 By Nasdaq GlobeNewswire
-
21 Feb 2023 07:30:49 By Nasdaq GlobeNewswire
-
09 Feb 2023 08:00:38 By Nasdaq GlobeNewswire
-
22 Dec 2022 08:00:46 By Nasdaq GlobeNewswire
-
21 Dec 2022 16:05:00 By Nasdaq GlobeNewswire
-
15 Dec 2022 08:00:42 By Nasdaq GlobeNewswire
-
28 Nov 2022 08:00:01 By Nasdaq GlobeNewswire
-
Cognition Therapeutics Launches Neuroscience Thought Leader Conversations Podcast/Webinar Series
21 Nov 2022 08:00:33 By Nasdaq GlobeNewswire
-
Cognition Therapeutics Announces Closing of Public Offering
15 Nov 2022 12:55:47 By Nasdaq GlobeNewswire
-
Cognition Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
14 Nov 2022 08:00:07 By Nasdaq GlobeNewswire
-
Cognition Therapeutics Announces Pricing of Public Offering
10 Nov 2022 08:00:01 By Nasdaq GlobeNewswire
-
12 Oct 2022 08:00:01 By Nasdaq GlobeNewswire
-
Cognition Therapeutics Appoints CNS Drug Development Expert to VP Clinical Development
11 Oct 2022 08:00:01 By Nasdaq GlobeNewswire
-
29 Sep 2022 07:30:00 By Nasdaq GlobeNewswire
-
27 Sep 2022 07:32:00 By Nasdaq GlobeNewswire
-
Cognition Therapeutics Announces Participation in September Investment Conferences
06 Sep 2022 07:32:00 By Nasdaq GlobeNewswire